Medicare Enrolled
Dr. Sean Murphy, MD
Pulmonary Disease · Winston Salem, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Murphy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Murphy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Murphy
Dr. Sean Murphy is a pulmonary disease specialist in Winston Salem, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Murphy performed 1,408 Medicare services across 1,248 unique beneficiaries.
Between the years covered by Open Payments, Dr. Murphy received a total of $6,706 from 50 pharmaceutical and/or device companies across 358 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Murphy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 21% volume in NC
$6,706 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,408
Medicare services
Top 21% in NC for pulmonary disease
1,248
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~70 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
310 | $86 | $150 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
224 | $18 | $56 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
125 | $162 | $847 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
115 | $16 | $45 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
111 | $36 | $71 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
71 | $34 | $70 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
63 | $127 | $200 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
50 | $13 | $25 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
47 | $60 | $102 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
43 | $25 | $55 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $115 | $226 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
36 | $14 | $25 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
35 | $26 | $80 |
| New patient office visit, complex (60-74 min) | 33 | $156 | $284 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $61 | $100 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
22 | $50 | $100 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
21 | $10 | $31 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
14 | $27 | $81 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
12 | $9 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,706
Total received (2018-2024)
Avg $958/year across 7 years
Top 28% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
358
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,706 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,558
2023
$1,094
2022
$748
2021
$604
2020
$509
2019
$682
2018
$1,512
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$308
United Therapeutics Corporation
$248
Boehringer Ingelheim Pharmaceuticals, Inc.
$152
Baxter Healthcare
$110
Regeneron Healthcare Solutions, Inc.
$97
Takeda Pharmaceuticals U.S.A., Inc.
$95
GlaxoSmithKline, LLC.
$82
GENZYME CORPORATION
$77
Mylan Specialty L.P.
$73
Actelion Pharmaceuticals US, Inc.
$48
Merck Sharp & Dohme LLC
$48
Grifols USA, LLC
$44
Gilead Sciences, Inc.
$39
INOGEN, INC.
$35
Electromed, Inc.
$28
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Shionogi Inc
$17
Mallinckrodt Hospital Products Inc.
$15
Philips North America LLC
$14
Top 3 companies account for 45.5% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,063
Gilead Sciences, Inc.
$935
AstraZeneca Pharmaceuticals LP
$714
Boehringer Ingelheim Pharmaceuticals, Inc.
$619
United Therapeutics Corporation
$390
Grifols USA, LLC
$276
Takeda Pharmaceuticals U.S.A., Inc.
$222
Mylan Specialty L.P.
$210
GENZYME CORPORATION
$192
Baxter Healthcare
$176
Actelion Pharmaceuticals US, Inc.
$172
Mallinckrodt Hospital Products Inc.
$170
Regeneron Healthcare Solutions, Inc.
$163
Sunovion Pharmaceuticals Inc.
$139
Philips Electronics North America Corporation
$117
Novartis Pharmaceuticals Corporation
$100
Electromed, Inc.
$98
Genentech USA, Inc.
$79
Merck Sharp & Dohme LLC
$77
Merck Sharp & Dohme Corporation
$75
Shionogi Inc
$61
PFIZER INC.
$52
Inogen, Inc.
$51
Insmed, Inc.
$39
Alexion Pharmaceuticals, Inc.
$36
INOGEN, INC.
$35
HOSPIRA, INC.
$34
Mallinckrodt Enterprises LLC
$33
Paratek Pharmaceuticals, Inc.
$27
Covis Pharma GmBH
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Phadia US Inc.
$25
Advanced Respiratory, Inc
$20
Amgen Inc.
$20
La Jolla Pharmaceutical Company
$19
Exeltis, USA Inc.
$19
Bio Products Laboratory USA, Inc.
$18
Breathe Technologies, Inc.
$17
Mallinckrodt LLC
$17
Teva Pharmaceuticals USA, Inc.
$16
BOSTON SCIENTIFIC CORPORATION
$15
E.R. Squibb & Sons, L.L.C.
$15
Philips North America LLC
$14
ADVANCED RESPIRATORY, INC
$14
Janssen Pharmaceuticals, Inc
$14
Sun Pharmaceutical Industries Inc.
$12
PORTOLA PHARMACEUTICALS, INC.
$12
Boston Scientific Corporation
$12
Shire North American Group Inc
$11
Biofrontera Inc.
$9
Top 3 companies account for 40.4% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ALVESCO · AMELUZ · ANORO · ANORO ELLIPTA · AREXVY · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BLU-U · BREO · BREZTRI · BREZTRI AEROSPHERE · DIFICID · DUPIXENT · ELIQUIS · EXALT Model D · FASENRA · Fetroja · GAMMAGARD · GENERAL BRONCHIAL THERMOPLASTY · GIAPREZA · GLASSIA · Gammaplex · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN · INOGEN AT HOME STATIONARY CONCENTRATOR · ImmunoCAP · LOKELMA · LONHALA MAGNAIR · LUMAKRAS · Life 2000 Ventilation System · Life2000 Ventilation System · NUCALA · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Odomzo · PANZYGA · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · SMARTVEST · SOLIRIS · STIOLTO RESPIMAT · SYMBICORT · Soliris · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · Utibron · Veklury · Wellcentive Undiv · XARELTO · XOLAIR · Xembify · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
17
Per 100K population
4.4
County median income
$65,541
Nearest hospital
NOVANT HEALTH FORSYTH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Murphy is a clinical cardiology specialist, with above-average Medicare volume (top 21% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Murphy experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Murphy performed 310 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Murphy receive payments from pharmaceutical companies?
Yes. Dr. Murphy received a total of $6,706 from 50 companies across 358 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Murphy's costs compare to other pulmonary diseases in Winston Salem?
Dr. Murphy's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Murphy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Winston Salem
Browse pulmonary diseases in Winston Salem ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NC
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NC
Which NC pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology